The rollback of key environmental regulations appears poised to increase health risks for populations vulnerable to air pollution. Asthma rates among children-a public health issue referenced in U.S. policy documents-may rise due to relaxed restrictions on emissions and smog-producing activities. Economic arguments behind deregulation likely emphasize reduced burdens on industry profitability; however, this appears offset by significant projected healthcare costs related to unmanaged respiratory illnesses.India could derive lessons from these developments as it balances industrial growth with public health imperatives amid rising urban pollution levels domestically. A important takeaway is the demonstrated importance of institutional frameworks like dedicated health programs (e.g., CDC’s eliminated office) that directly respond to environmental impacts on disease prevention-a strategy Indian policymakers could consider strengthening as urbanization accelerates nationwide with comparable challenges such as rising respiratory conditions linked directly w Delhi etc